The Issue of Multicenter Trials: Can One Multicenter Trial be an Alternative to the Concept of “At Least Two Pivotal Studies”?

Food and Drug Administration. “Guidelines for the Format and Content of the Clinical and Statistical Sections of New Drug Applications.” Legislation, Professional and Consumer Affairs, Rockville, Maryland, 1988.

Troendle GJ . Preparing the clinical section of a new drug application. Reg Aff. 1989;1:49–54.

Nevius SE . Assessment of evidence from a single multicenter trial. Am Stat Assoc Biopharmaceutical Section. 1988;43–45.